Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lechu Yu"'
Autor:
Wenya Weng, Tingwen Ge, Yi Wang, Lulu He, Tinghao Liu, Wanning Wang, Zongyu Zheng, Lechu Yu, Chi Zhang, Xuemian Lu
Publikováno v:
Diabetes & Metabolism Journal, Vol 44, Iss 4, Pp 566-580 (2020)
BackgroundFibroblast growth factor 21 (FGF21) has been only reported to prevent type 1 diabetic nephropathy (DN) in the streptozotocin-induced type 1 diabetes mellitus (T1DM) mouse model. However, the FVB (Cg)-Tg (Cryaa-Tag, Ins2-CALM1) 26OVE/PneJ (O
Externí odkaz:
https://doaj.org/article/c4a1356292b248dca8ee2cb5ab89035d
Publikováno v:
Diabetes & Metabolism Journal, Vol 44, Iss 1, Pp 158-172 (2020)
BackgroundEpithelial-to-mesenchymal transition (EMT) is required for renal fibrosis, which is a characteristic of diabetic nephropathy (DN). Our previous study demonstrated that fibroblast growth factor 21 (FGF21) prevented DN associated with the sup
Externí odkaz:
https://doaj.org/article/01b0e06cd9114707b9dbc20a16b70712
Autor:
Yi Wang, Zongyu Zheng, Chi Zhang, Tinghao Liu, Lechu Yu, Lulu He, Wenya Weng, Wanning Wang, Xuemian Lu, Tingwen Ge
Publikováno v:
Diabetes & Metabolism Journal
Diabetes & Metabolism Journal, Vol 44, Iss 4, Pp 566-580 (2020)
Diabetes & Metabolism Journal, Vol 44, Iss 4, Pp 566-580 (2020)
Background Fibroblast growth factor 21 (FGF21) has been only reported to prevent type 1 diabetic nephropathy (DN) in the streptozotocin-induced type 1 diabetes mellitus (T1DM) mouse model. However, the FVB (Cg)-Tg (Cryaa-Tag, Ins2-CALM1) 26OVE/PneJ (